|
VPS37A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.807700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.781800E-03 |
| Normal-vs-Stage2 |
9.785600E-01 |
| Normal-vs-Stage3 |
1.815520E-04 |
| Normal-vs-Stage4 |
3.360900E-03 |
| Stage1-vs-Stage2 |
2.830000E-01 |
| Stage1-vs-Stage3 |
5.448300E-02 |
| Stage1-vs-Stage4 |
2.296400E-01 |
| Stage2-vs-Stage3 |
5.568300E-02 |
| Stage2-vs-Stage4 |
1.117580E-01 |
| Stage3-vs-Stage4 |
6.537000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.836500E-04 |
| Normal-vs-AfricanAmerican |
5.941900E-03 |
| Normal-vs-Asian |
2.897700E-02 |
| Caucasian-vs-AfricanAmerican |
5.979000E-01 |
| Caucasian-vs-Asian |
6.449800E-01 |
| AfricanAmerican-vs-Asian |
6.896400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.836020E-04 |
| Normal-vs-Female |
2.024400E-02 |
| Male-vs-Female |
2.950000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.424000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.552190E-02 |
| Normal-vs-Age(61-80Yrs) |
9.99879999999953E-05 |
| Normal-vs-Age(81-100Yrs) |
6.947800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.205200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.720000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.558800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.783640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.826600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.136800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.350200E-01 |
| Normal-vs-Grade 2 |
4.003800E-02 |
| Normal-vs-Grade 3 |
1.235730E-04 |
| Normal-vs-Grade 4 |
5.58969999999714E-05 |
| Grade 1-vs-Grade 2 |
3.166000E-02 |
| Grade 1-vs-Grade 3 |
3.640700E-03 |
| Grade 1-vs-Grade 4 |
5.556700E-03 |
| Grade 2-vs-Grade 3 |
1.030570E-01 |
| Grade 2-vs-Grade 4 |
1.856090E-02 |
| Grade 3-vs-Grade 4 |
3.205400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.449800E-02 |
| Normal-vs-ccB subtype |
1.421260E-03 |
| ccA subtype-vs-ccB subtype |
1.749550E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.899400E-03 |
| Normal-vs-N1 |
4.783600E-01 |
| N0-vs-N1 |
8.907800E-01 |
|
|
